- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe aplastic anaemia Severe thrombocytopenia
- Meeting Date: July 2026
Eltrombopag – July 2026
- Tablet 75 mg (as olamine)
Public Summary Documents
Last updated
13 November 2026
